Procollagen 1 and melan-a expression in desmoplastic melanomas

American Journal of Dermatopathology

Volumn 31, Issue 2, 2009, Pages 173-176

  Leinweber, Bernd ^a,b   Hofmann Wellenhof, Rainer ^a   Kaddu, Steven ^a   McCalmont, Timothy H ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atypical fibroxanthoma; Desmoplastic melanoma; Melan A; Procollagen 1

Indexed keywords

CYTOKERATIN; MELAN A; PROCOLLAGEN; PROCOLLAGEN 1; PROTEIN S 100; UNCLASSIFIED DRUG; MART1 ANTIGEN; TUMOR ANTIGEN; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CELL STRUCTURE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MELANOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN BIOPSY; SPINDLE CELL; TUMOR CELL; BIOPSY; DIFFERENTIAL DIAGNOSIS; METABOLISM; MIDDLE AGED; PATHOLOGY; SENSITIVITY AND SPECIFICITY; SKIN TUMOR;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MIDDLE AGED; NEOPLASM PROTEINS; PROCOLLAGEN; S100 PROTEINS; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 67649639816     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/DAD.0b013e3181930b85     Document Type: Article

References (20)

1. Conley J, Lattes R, Orr W. Desmoplastic malignant melanoma (a rare variant of spindle cell melanoma). Cancer. 1971;28:914-936.
2. Krustrup D, Rossen K, Thomsen HK. Procollagen 1 - a marker of fibroblastic and fibrohistiocytic skin tumors. J Cutan Pathol. 2006;33: 614-618.
3. Mar N, Ruben B, McCalmont T. Procollagen I: a useful immunoperox-idase reagent for the diagnosis of atypical fibroxanthoma [abstract]. J Cutan Pathol. 2002;29:577.
4. Jensen K, Wilkinson B, Wines N, et al. Procollagen 1 expression in atypical fibroxanthoma and other tumors. J Cutan Pathol. 2004;31:57-61.
5. de Feraudy S, Mar N, McCalmont TH. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma. Am J Surg Pathol. 2008;32:1111-1122.
6. de Almeida LS, Requena L, Rütten A, et al. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases. Am J Dermatopathol. 2008;30:207-215.
7. Busam KJ, Mujumdar U, Hummer AJ, et al. Cutaneous desmoplastic melanoma: reappraisal of morphologic heterogeneity and prognostic factors. Am J Surg Pathol. 2004;28:1518-1525.
8. Sangüeza M, Zelger B. Melanoma simulating atypical fibroxanthoma. Am J Dermatopathol. 2007;29:551-554.
9. Dettrick A, Strutton G. Atypical fibroxanthoma with perineural or intraneural invasion: report of two cases. J Cutan Pathol. 2006;33: 318-322.
10. Longacre TA, Egbert BM, Rouse RV. Desmoplastic and spindle-cell malignant melanoma. An immunohistochemical study. Am J Surg Pathol. 1996;20:1489-1500.
11. Blessing K, Sanders DSA, Grant JJH. Comparison of immunohisto-chemical staining of the novel antibody melan-a with S 100 protein and HMB-45 in malignant melanoma and melanoma variants. Histopathology. 1998;32:139-146.
12. Anstey A, Cerio R, Ramnarain N, et al. Desmoplastic malignant melanoma. An immunocytochemical study of 25 cases. Am J Dermatopathol. 1994;16:14-22.
13. Granter SR, Weilbaecher KN, Quigley C, et al. Microphthalmia transcription factor. Not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma. Am J Dermatopathol. 2001;23:185-189.
14. Ohsie SJ, Sarantopoulos GP, Cochran AJ, et al. Immunohistochemical characteristics of melanoma. J Cutan Pathol. 2008;35:433-444.
15. Kucher C, Zhang PJ, Pasha T, et al. Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi. Am J Dermatopathol. 2004;26:452-457.
16. Lim E, Browning J, MacGregor D, et al. Desmoplastic melanoma: comparison of expression of differentiation antigens and cancer testis antigens. Melanoma Res. 2006;16:347-355.
17. Carlson JA, Dickersin GR, Sober AJ, et al. Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases. Cancer. 1995;75: 478-494.
18. Riccioni L, Di Tommaso L, Collina G. Actin-rich desmoplastic melanoma. Report of three cases. Am J Dermatopathol. 1999;21: 537-541.
19. Fetsch PA, Marincola FM, Abatia A. The new melanoma markers: MART-1 and Melan-A (the NIH experience). Am J Surg Pathol. 1999;23: 607-610.
20. Busam KJ, Chen Y, Old LJ, et al. Expression of Melan-A (MART-1) in benign melanocytic nevi and primary cutaneous malignant melanoma. Am J Surg Pathol. 1998;22:976-982.